This activity is expired and is no longer available for CME credit.


Taming the Difficult Diabetic Eye: Examining New Options for Treatment

Author(s)/Faculty: John W. Kitchens, MD; Sophie J. Bakri, MD; Andrew A. Moshfeghi, MD, MBA; Michael W. Stewart, MD
Release Date: 12/15/2015Expiration Date: 12/14/2016
Credit Type: CMENumber of Credits: 0
Content Type: LectureProvider:
Proliferative diabetic retinopathy has long been one of the most challenging ocular conditions, as damage can be asymptomatic and often starts in the peripheral retina, which is not visualized by standard imaging techniques. In addition, although laser has been shown to be effective at inhibiting progression, vision loss remains a concern. New imaging technology has significantly expanded the 7 central fields, offering a more complete view of the retina, which could allow clinicians to diagnose diabetic eye disease earlier. In addition, clinical trial data have shown that aflibercept and ranibizumab both achieved regression of vision loss, and have been approved for the treatment of diabetic retinopathy in patients with diabetic macular edema. Leading clinicians will review the latest imaging techniques as well as the data and clinical experience supporting the use of anti-VEGF agents for diabetic retinopathy to address the importance of early diagnosis and treatment in achieving the best outcomes for patients. The faculty will also review case examples to apply theory to practice.